Session » Miscellaneous Rheumatic & Inflammatory Diseases Poster I
- 10:30AM-12:30PM
-
Abstract Number: 0285
Anti-THSD7A Antibodies Are Not Broadly Associated with IgG4-Related Disease or IgG4-Related Membranous Nephropathy
- 10:30AM-12:30PM
-
Abstract Number: 0293
Assessment of Skin Cancer Risk in Autoimmune Diseases: A Multivariate Analysis Using a National Inpatient Database
- 10:30AM-12:30PM
-
Abstract Number: 0313
Cardiac Sarcoidosis Is Associated with a High Mortality: Retrospective Analysis of a Cohort at Mayo Clinic Florida
- 10:30AM-12:30PM
-
Abstract Number: 0306
Cardiovascular Risk Estimated with the New PREVENT Calculator and Disease Activity in Patients with Rheumatoid and Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0309
Characteristics and Factors Associated with Treatment Response Among Patients with Eosinophilic Fasciitis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0297
Characteristics of Adult-Onset Still’s Disease Skin Eruption in Individuals of Sub-Saharan Ancestry
- 10:30AM-12:30PM
-
Abstract Number: 0286
Damage Associated with Disease-Specific Effects and Diagnostic or Therapeutic Procedures Is Highly Prevalent in IgG4-Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 0290
Deucravacitinib Long-term Efficacy Through 4 Years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program
- 10:30AM-12:30PM
-
Abstract Number: 0316
Development and Evaluation of the Adult-onset Still’s Disease Activity Index Based on Whole RNA-seq Analysis: A Novel Approach Independent of Tocilizumab Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0289
Effectiveness of Rituximab in IgG4 Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 0300
Evaluation of Long-term Primary Patency of Iliocaval Stenting in Patients with Retroperitoneal Fibrosis/chronic Periaortitis
- 10:30AM-12:30PM
-
Abstract Number: 0288
Hypersensitivity Pneumonitis with Autoimmune Features: A New Entity?
- 10:30AM-12:30PM
-
Abstract Number: 0310
I-CARE Program: Interest of Multidisciplinary Systematic Screening Program for Comorbidities for Patients Suffering from Arthritis Rheumatoid DiseasE: A Real Life Study
- 10:30AM-12:30PM
-
Abstract Number: 0305
Inflammatory T Cell Expansion in Yao Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0308
Interstitial Lung Disease as the First Clinical Manifestation of Connective Tissue Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0311
Investigation of Sarcoidosis-associated Neuropathy: Challenges with Diagnosis of Small Fiber Neuropathy
- 10:30AM-12:30PM
-
Abstract Number: 0287
Joint Involvement in Cystic Fibrosis: Description of Clinical Phenotypes
- 10:30AM-12:30PM
-
Abstract Number: 0292
Liver Disease Complicating Familial Mediterranean Fever: A Study on 57 Patients from the French Adult JIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0307
Mean Metacarpophalangeal Extension to Clinically Quantify Flexor Fibro-inflammatory Hand Involvement in Diabetes
- 10:30AM-12:30PM
-
Abstract Number: 0315
Microvascular Abnormalities Are Present in Autonomic Dysfunction: Results of a Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 0314
Microvascular Differences Between Acute and Chronic Cutaneous Graft versus Host Disease
- 10:30AM-12:30PM
-
Abstract Number: 0296
Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0295
Mycophenolate Mofetil in the Treatment of Patients with Isolated Cardiac Sarcoidosis
- 10:30AM-12:30PM
-
Abstract Number: 0294
Obesity and Risk of Autoimmune Diseases: Insights from the National Inpatient Sample
- 10:30AM-12:30PM
-
Abstract Number: 0301
Path to Diagnosis in Familial Mediterranean Fever (FMF)
- 10:30AM-12:30PM
-
Abstract Number: 0303
Phase 2b, Long-term Extension, Dose-ranging Study of Oral JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis: FRONTIER-2
- 10:30AM-12:30PM
-
Abstract Number: 0317
Progressive Fibrosing Intersticial Lung Disease of Autoimmune Origin and Antifibrotic Medication: NEREA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0298
RAY121, a Novel Recycling Monoclonal Antibody Against Complement C1s: Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase 1a First in Human Clinical Trial in Healthy Adults
- 10:30AM-12:30PM
-
Abstract Number: 0299
Real-World Tolerability of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0291
Safety of Biologic Therapy in Kidney Transplant Recipients with Inflammatory Diseases: Real-world Experience from a Tertiary Medical Center
- 10:30AM-12:30PM
-
Abstract Number: 0304
Severe Infection in COVID-19 Vaccinated Patients with Systemic Autoimmune Rheumatic Diseases on B Cell Targeted Therapies: Association with Neutrophil-lymphocyte Ratio
- 10:30AM-12:30PM
-
Abstract Number: 0318
The Relevance of a Positive ANA in New Patient Referrals to Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 0312
The Use of Electromyography as a Screening Tool in Sarcoidosis-associated Neuropathy
- 10:30AM-12:30PM
-
Abstract Number: 0302
TNFAIP3 Loss-of-function and Missense Mutations Demonstrate Clinically Diverse Presentations: A Multi-center Cohort Experience